References
- Khozin S, Coravos A. Decentralized trials in the age of real-world evidence and inclusivity in clinical investigations. Clin Pharm & Therapeutics 2019; DOI: 10.1002/cpt.1441.
- Apostolaros M, Babaian D, Corneli A et al. Legal, regulatory, and practical issues to consider when adopting decentralized clinical trials: Recommendations from the Clinical Trials Transformation Initiative. Therapeutic Innovation and Regulatory Science 2020; 54:779-787.
- Thomas L, Capistrant G. 50 State telemedicine gaps analysis: physician practice standards and licensure. Washington DC: American Telemedicine Association; 2017.
- Center for Connected Health Policy. State Telehealth Laws and Reimbursement Policies: a comprehensive scan of the 50 states and the district of Columbia. Public Health Institute; 2018.
- Cwiklicki M, Schiavone F, Klich J et al. Antecedents of use of e-health services in Central Eastern Europe: a qualitative comparative analysis. BMC Health Services Research 2020; 20; 171.
- Pham MT, Rajić A, Greig JD, et al. A scoping review of scoping reviews: advancing the approach and enhancing the consistency. Research Synthesis Methods, 2014, 5(4) Available at http://onlinelibrary.wiley.com/doi/10.1002/jrsm.1123/ pdf (Accessed 20th August 2021).
- Arksey H, O’Malley L. Scoping studies: towards a methodological framework, International Journal of Social Research Methodology; 2005, 8(1):19-32.
- Levac D, Colquhoun H, and O’Brien K. Scoping studies: advancing the methodology. Implementation Science, 2010, 5(1):69 doi: 10.1186/1748-5908-5-69.
- COVID-19 and clinical trials: The Medidata perspective, Medidata Solutions, May 4, 2020, medidata.com.
- McKinsey & Company. No place like home? Stepping up the decentralization of clinical trials. Available at: https://www. mckinsey.com/industries/life-sciences/our-insights/no-place-like-home-stepping-up-the-decentralization-of-clinical-trials. Accessed on: November 2021
- Zarka A et al. Virtual clinical trials: Perspectives in Dermatology. Dermatology 2020; 236; 375-382. DOI:10.1159/000506418
- Apostolaros M et al. Legal, Regulatory, and Practical Issues to Consider When Adopting Decentralized Clinical Trials: Recommendations From the Clinical Trials Transformation Initiative. Ther Innov Regul Sci . 2020 Jul;54(4):779-787. doi: 10.1007/s43441-019-00006-4.
- Van Norman GA. Decentralized Clinical Trials.The Future of Medical Product Development? JACC Basic Transl Sci. 2021 Apr 27;6(4):384-387. doi: 10.1016/j.jacbts.2021.01.011
- Krishna S. Gunturu et al. Clinical Trials in the Era of Digital Engagement: A SWOG Call to Action. JCO Clin Cancer Inform. 2020 Mar;4:254-258. doi: 10.1200/CCI.19.00128
- Yu Zhuang et al. Applying Blockchain Technology for Health Information Exchange and Persistent Monitoring for Clinical Trials. AMIA Annu Symp Proc. 2018 Dec 5;2018:1167-1175.
- De Brouwer W et al. Empowering clinical research in a decentralized world. NPJ Digit Med. 2021 Jul 1;4(1):102. doi: 10.1038/s41746-021-00473-w.
- Sundquist S, Batist G, Brodeur-Robb K, et al. CRAFT-A Proposed Framework for Decentralized Clinical Trials Participation in Canada. Curr Oncol. 2021 Sep 30;28(5):3857-3865. doi: 10.3390/curroncol28050329.
- Tan AC et al. Adapting to a Pandemic - Conducting Oncology Trials during the SARS-CoV-2 Pandemic 2020. Clin Cancer Res. 2020 Jul 1;26(13):3100-3103. doi: 10.1158/1078-0432. CCR-20-1364.
- Haak D et al. DICOM for Clinical Research: PACS-Integrated Electronic Data Capture in Multi-Center Trials. J Digit Imaging. 2015 Oct;28(5):558-66. doi: 10.1007/s10278-015-9802-8.
- Lehrach H. Virtual Clinical Trials, an Essential Step in Increasing the Effectiveness of the Drug Development Process. Public Health Genomics. 2015;18(6):366-71. doi: 10.1159/000441553.
- Sommer C, Zuccolin D, Arnera V, Schmitz N, Adolfsson P, Colombo N, Gilg R, McDowell B. Building clinical trials around patients: Evaluation and comparison of decentralized and conventional site models in patients with low back pain. Contemp Clin Trials Commun. 2018 Jun 28;11:120-126. doi: 10.1016/j.conctc.2018.06.008.
- Dorsey ER et al. The triple aim of clinical research. Clin Trials. 2021;18(4):511-513. doi: 10.1177/17407745211001522
- Spertus JA et al. Novel Trial Design: CHIEF-HF. Circ Heart Fail. 2021;14(3):e007767. doi: 10.1161/CIRCHEARTFAILURE.120.007767
- Lee EQ et al. Report of National Brain Tumor Society roundtable workshop on innovating brain tumor clinical trials: building on lessons learned from COVID-19 experience. Neuro Oncol. 2021 Aug 2;23(8):1252-1260. doi: 10.1093/neuonc/noab082
- Gouda P et al. Feasibility of Incorporating Voice Technology and Virtual Assistants in Cardiovascular Care and Clinical Trials. Curr Cardiovasc Risk Rep. 2021;15(8):13. doi: 10.1007/ s12170-021-00673-9
- Persky S. A Virtual Home for the Virtual Clinical Trial. J Med Internet Res. 2020 Jan 3;22(1):e15582. doi: 10.2196/15582
- Hashem H et al. Obstacles and Considerations Related to Clinical Trial Research During the COVID-19 Pandemic. Front Med (Lausanne). 2020 23;7:598038. doi: 10.3389/ fmed.2020.598038
- McGoohan K et al. A Preliminary Investigation of the Views of People With Parkinson’s (With and Without Psychosis) and Caregivers on Participating in Clinical Trials During the Covid-19 Pandemic: An Online Survey. Front Psychiatry. 2020 Dec 23;11:602480. doi: 10.3389/fpsyt.2020.602480.
- Ali Z et al. High adherence and low dropout rate in a virtual clinical study of atopic dermatitis through weekly reward-based personalized genetic lifestyle reports. PLoS One. 2020 Jul 2;15(7):e0235500. doi: 10.1371/journal.pone.0235500.
- Yaakov RA et al. Enhancing Patient Centricity and Advancing Innovation in Clinical Research with Virtual Randomized Clinical Trials (vRCTs). Diagnostics (Basel). 2021 Jan 21;11(2):151. doi: 10.3390/diagnostics11020151
- Wang H et al. Conducting a Virtual Clinical Trial in HER2-Negative Breast Cancer Using a Quantitative Systems Pharmacology Model With an Epigenetic Modulator and Immune Checkpoint Inhibitors. Front Bioeng Biotechnol. 2020 Feb 25;8:141. doi: 10.3389/fbioe.2020.00141.
- Kadakia KT et al. Virtual Clinical Trials in Oncology-Overview, Challenges, Policy Considerations, and Future Directions. JCO Clin Cancer Inform. 2021 Apr;5:421-425. doi: 10.1200/ CCI.20.00169.
- Yan Zhuang et al. Development of A Blockchain Framework for Virtual Clinical Trials. AMIA Annu Symp Proc. 2021 Jan 25;2020:1412-1420.
- Ieronimakis KM et al. Leveraging Tele-Critical Care Capabilities for Clinical Trial Consent. Crit Care Explor. 2020;2(7):e0167. doi: 10.1097/CCE.0000000000000167
- Schneider RB et al. Design of a virtual longitudinal observational study in Parkinson’s disease (AT-HOME PD). Ann Clin Transl Neurol. 2021 Feb;8(2):308-320. doi: 10.1002/ acn3.51236.
- Marra C et al. Use of connected digital products in clinical research following the COVID-19 pandemic: a comprehensive analysis of clinical trials. BMJ Open. 2021 Jun 22;11(6):e047341. doi: 10.1136/bmjopen-2020-047341.
- Getz K et al. Assessing the Scope and Predictors of Intentional Dose Non-adherence in Clinical Trials. Ther Innov Regul Sci. 2020 Nov;54(6):1330-1338. doi: 10.1007/s43441-020-00155-x.
- Vinay Singh et al. COVID-19 and Clinical Trials: Current Challenges and Future Directions. Rev Recent Clin Trials. 2021;16(3):258-261. doi: 10.2174/1574887116666210122160705.
- Coert RMH, Timmis JK, Boorsma A, Pasman WJ. Stakeholder Perspectives on Barriers and Facilitators for the Adoption of Virtual Clinical Trials: Qualitative Study. J Med Internet Res. 2021 Jul 6;23(7):e26813. doi: 10.2196/2681
- Samei E et al. Virtual Clinical Trials: Why and What (Special Section Guest Editorial). J Med Imaging (Bellingham). 2020 Jul;7(4):042801. doi: 10.1117/1.JMI.7.4.042801.
- Chiamulera C, Mantovani E, Tamburin S. Remote clinical trials: A timely opportunity for a virtual reality approach and its potential application in neurology. Br J Clin Pharmacol. 2021 Oct;87(10):3639-3642. doi: 10.1111/bcp.14922
- Petrini C, Mannelli C, Riva L, et al. Decentralized clinical trials (DCTs): A few ethical considerations. Front Public Health. 2022 Dec 15;10:1081150. doi: 10.3389/fpubh.2022.1081150
- Goodson N, Wicks P, Morgan J, Hashem L, Callinan S, Reites J. Opportunities and counterintuitive challenges for decentralized clinical trials to broaden participant inclusion. NPJ Digit Med. 2022 May 5;5(1):58. doi: 10.1038/s41746-022-00603-y
- Coyle J, Rogers A, Copland R, et al. Trials@Home Consortium. A secondary qualitative analysis of stakeholder views about participant recruitment, retention, and adherence in decentralised clinical trials (DCTs). Trials. 2022 Jul 30;23(1):614. doi: 10.1186/s13063-022-06521-4.
- Adams DV, Long S, Fleury ME. Association of Remote Technology Use and Other Decentralization Tools With Patient Likelihood to Enroll in Cancer Clinical Trials. JAMA Netw Open. 2022 Jul 1;5(7):e2220053. doi: 10.1001/jamanetworkopen.2022.20053
- Moore J, Goodson N, Wicks P, Reites J. What role can decentralized trial designs play to improve rare disease studies? Orphanet J Rare Dis. 2022 20;17(1):240. doi: 10.1186/ s13023-022-02388-5
- Rogers A, De Paoli G, Subbarayan S, et al. Trials@Home Consortium. A systematic review of methods used to conduct decentralised clinical trials. Br J Clin Pharmacol. 2022;88(6):2843-2862. doi: 10.1111/bcp.15205.
- De Las Heras B, Daehnke A, Saini KS, et al. Role of decentralized clinical trials in cancer drug development: Results from a survey of oncologists and patients. Digit Health. 2022 May 25;8:20552076221099997. doi: 10.1177/20552076221099997.
- DiMasi JA, Smith Z, Oakley-Girvan I, et al. Assessing the Financial Value of Decentralized Clinical Trials. Ther Innov Regul Sci. 2023 Mar;57(2):209-219. doi: 10.1007/s43441-022-00454-5
- De Jong A, van Rijssel T, Zuidgeest M et al. Opportunities and challenges for decentralized clinical trials: European Regulators Perspective. Clinical Pharmacology & Therapeutics 2022; 112 (2):344-352. Doi: https://doi.org/10.1002/cpt.2628